AbbVie reported strong earnings on demand for its Humira drug and said it could deliver strong long-term growth without another big merger bid.» Read More
Liberty Media Chairman John Malone is pushing for major consolidation in the cable industry, reports CNBC's Julia Boorstin.
Japan's Softbank received the final approval it needed from U.S. regulators for its $21.6 billion bid to take control of No. 3 US wireless provider Sprint Nextel.
Matthew Toole, Thomson Reuters, and Amanda Levin, Mergermarket editor of the Americas, debate whether to expect a turnaround in dealmaking for the second half of the year.
Some companies can create a treasure trove of value simply by making a strategic acquisition, said Cramer.
Orchard Supply Hardware Stores has filed for Chapter 11 bankruptcy protection, with rival retailer Lowe's Companies set to buy the majority of its assets for $205 million in cash.
Starboard Value is pressuring Smithfield to explore a break-up rather than go ahead with a $4.7 billion takeover by a Chinese meat producer.
Media giant Gannett announced on Thursday that it was merging with television station Belo, in a $1.5 billion deal that would expands Gannett's reach into broadcast.
Empire, operator of Canadian grocery chain Sobeys, plans to acquire Safeway's assets in Canada for billions, nearly doubling its reach in the Canadian western provinces.
Decades-old laws barring foreign ownership of farmland may complicate Shuanghui's $4.7 billion planned purchase of Smithfield Foods.
China Construction America has been investing in the US for 28 years. CCA's CEO says they still have to overcome distrust as it is majority-owned by the Chinese government.
Chinese IVC's bought the vitamin for $63.4 million in 2010. IVC products are in Walmart, Walgreens and RiteAid, but the goal is much bigger: selling to the Chinese consumer.
Despite all the negative headlines, Chinese investment in the US hit an all-time record in 2012: $6.5 billion. It will likely surpass that level in 2013.
Sprint Nextel said its Japanese suitor SoftBank granted it a waiver allowing it to consider a $25.5 billion rival bid by Dish Network, as pressure mounts on SoftBank to sweeten its offer for the No. 3 U.S. wireless carrier.
Actavis received and rejected a takeover offer from Mylan last week that valued the generic drugmaker at more than $15 billion, a person familiar with the situation said.
The special committee of Dell board of directors is seeking more details on Carl Icahn's proposed offer for the computer maker.
James Woolery, Cadwalader Wickersham & Taft, discusses the impact of investor activism on public companies.
James Woolery, Cadwalader Wickersham & Taft, provides an insider's look at the some of the biggest mergers and acquisitions on Wall Street.
John Legere, T-Mobile US, explains how he plans to take on rivals; and discusses his company's merger with MetroPCS. The new company will now be known as T-Mobile USA, and will trade under the symbol TMUS.
A proposed merger of Valeant Pharmaceuticals International Inc and Actavis Inc. was put on hold after the two drugmakers failed to agree on terms of a deal.
Ralph Schlosstein,Evercore Partners; and Blair Effron Centerview Partners, explain how smaller M&A firms are taking a larger share of the market away from bigger firms.